East Asian NSCLC patients have exhibited heterogeneous EGFR mutation rates of 24–40% for all histologic subtypes, with rates of 24.0% in Japanese patients [31], 26.7% in Korean patients [32], and 30.0% in Chinese patients [33]. Here, EGFR is linked to non-small cell lung carcinoma.